Entrada Therapeutics (TRDA) Shares Outstanding (2020 - 2026)

Entrada Therapeutics' Shares Outstanding history runs 7 years deep, the most recent figure standing at $38.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 2.31% year-over-year to $38.8 million; the TTM figure through Mar 2026 stood at $38.8 million (up 2.31% YoY), while the FY2025 annual figure was $38.3 million, up 1.89% from the prior year.
• Shares Outstanding was $38.8 million for Q1 2026 at Entrada Therapeutics, up from $38.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $38.8 million in Q1 2026 to a low of $31.3 million in Q1 2022.
• Historically, Shares Outstanding has averaged $35.0 million across 5 years, with a median of $33.6 million in 2024.
• Biggest YoY gain for Shares Outstanding was 2358.97% in 2022; the steepest drop was 0.55% in 2022.
• A 5-year view of Shares Outstanding shows it stood at $31.4 million in 2022, then advanced by 6.51% to $33.4 million in 2023, then gained by 12.37% to $37.6 million in 2024, then climbed by 1.89% to $38.3 million in 2025, then grew by 1.4% to $38.8 million in 2026.
• The last three Shares Outstanding figures came in at $38.8 million (Q1 2026), $38.3 million (Q4 2025), and $38.2 million (Q3 2025), per Business Quant data.